RYAH Group, Inc.

RYAH Group Inc., a technology company, provides personalized wellness ecosystem of IoT-connected medical devices, AI analytics, and big data to medical cannabis industry in the United States and internationally. The company offers RYAH Smart Inhaler app, a volumetric airflow sensor gives the ability to track and control of inhaling; RYAH Smart Patch app, which provides users the ability to boost their patch for on-demand relief; and RYAH MD, a platform for health practitioners to remotely monitor and manage their patients' vaporization and patch regimen. In addition, it engages in sale of vaporizers, cartridges, filling machines, and other products related to medical cannabis. The company is based in Brooklyn, New York.

RYAH Group, Inc. trades as RYAHF on OTC. The company is classified in Healthcare / Medical - Healthcare Information Services and reports in USD.

The current profile places the business in Medical - Healthcare Information Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $168,127 of revenue and -$16.22M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

RYAH Group, Inc. can be compared against peers such as Aurora Spine Corporation, Cell Source, Inc., CareView Communications, Inc., Guided Therapeutics, Inc., Immunovia AB (publ), Pharma-Bio Serv, Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $2.24M, beta of -6.64, and return on equity of +3609.5%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

RYAHF currently shows total debt of $19,975 and beta of -6.64. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://ryah.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.